Get the Stockscreener App
3.42
7.89%
0.25
After Hours:
3.49
0.07
+2.05%
Mangoceuticals Inc stock is traded at $3.42, with a volume of 254.48K.
It is up +7.89% in the last 24 hours and up +29.06% over the past month.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
See More
Previous Close:
$3.17
Open:
$3.13
24h Volume:
254.48K
Relative Volume:
3.84
Market Cap:
$8.50M
Revenue:
$755.00K
Net Income/Loss:
$-9.33M
P/E Ratio:
-0.5989
EPS:
-5.71
Net Cash Flow:
$-5.43M
1W Performance:
+25.74%
1M Performance:
+29.06%
6M Performance:
-36.38%
1Y Performance:
-47.79%
1-Day Range:
$2.98
$3.44
1-Week Range:
$2.7644
$3.44
52-Week Range:
$2.07
$16.80
Mangoceuticals Inc Stock (MGRX) Company Profile
Name
Mangoceuticals Inc
Sector
Industry
Phone
(833) 626-4679
Address
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
3.42 | 8.50M | 755.00K | -9.33M | -5.43M | -5.71 |
|
VEEV
Veeva Systems Inc
|
239.43 | 38.87B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
74.78 | 12.92B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
58.26 | 10.88B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
64.99 | 10.23B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
112.07 | 9.71B | 1.15B | 96.70M | -161.99M | 1.09 |
Mangoceuticals Inc Stock (MGRX) Latest News
Mangoceuticals advances in H1N1 and H5N1 studies - Investing.com
Mangoceuticals Advances H1N1 Efficacy Study Noting - GlobeNewswire
Mangoceuticals executes exclusive distribution agreement with Propre - MSN
Mangoceuticals, Inc. Executes Exclusive Distribution - GlobeNewswire
Major Skincare Breakthrough: Clinical Tests Show New Plant-Based Treatment Outperforms Leading Solutions - StockTitan
Mangoceuticals, Inc. Finalizes Debt Conversion and Appointments - TipRanks
Mangoceuticals alters stockholder rights, amends bylaws - MSN
Mangoceuticals alters stockholder rights, amends bylaws By Investing.com - Investing.com Canada
Mangoceuticals, Inc. announced that it has received $0.55 million in funding - Marketscreener.com
Mangoceuticals, Inc. announced that it has received $0.05 million in funding - Marketscreener.com
Mangoceuticals, Inc. announced that it has received $0.3 million in funding - Marketscreener.com
Mangoceuticals (NASDAQ:MGRX) Enters into Securities Purchase Agreements with Institutional Investors - Defense World
Mangoceuticals (NASDAQ:MGRX) Enters into Securities Purchase Agreements with Institutional Accredited Investors - Defense World
Patent Acquisition Fuels Mangoceuticals (MGRX) Stock Surge During Extended Trading - Stocks Telegraph
Mangoceuticals Shares Rise 22%, Company Acquires Mushroom-Based Wellness and Innovations Patent - MarketWatch
Mangoceuticals Expands with Patent Acquisition in Nutraceuticals - TipRanks
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent - GlobeNewswire
Mangoceuticals inks new service agreement, issues equity By Investing.com - Investing.com Nigeria
Mangoceuticals inks new service agreement, issues equity - Investing.com India
Mangoceuticals probes unusual stock activity post-split - Investing.com
Mangoceuticals initiates investigation into potential stock manipulation - TipRanks
Mangoceuticals probes unusual stock activity post-split By Investing.com - Investing.com UK
Mangoceuticals, Inc. Initiates Investigation into Potential - GlobeNewswire
MangoRx Launches Investigation Into Suspicious Trading Activity After Stock Split - StockTitan
Mangoceuticals Inc. (MGRX) Quarterly 10-Q Report - Quartzy
Mangoceuticals Signs Consulting Deal with CFO Johnston - TipRanks
Mangoceuticals (MGRX) versus Its Competitors Head-To-Head Contrast - Defense World
Financial Comparison: Mangoceuticals (MGRX) versus Its Competitors - Defense World
Mangoceuticals (MGRX) and The Competition Head-To-Head Comparison - Defense World
Head to Head Survey: Mangoceuticals (MGRX) vs. The Competition - Defense World
Head to Head Review: Mangoceuticals (MGRX) versus Its Competitors - Defense World
Head-To-Head Analysis: Mangoceuticals (MGRX) vs. The Competition - Defense World
Mangoceuticals (MGRX) & Its Competitors Head to Head Comparison - Defense World
Reviewing Mangoceuticals (MGRX) & Its Competitors - Defense World
Mangoceuticals (MGRX) versus Its Peers Head to Head Comparison - Defense World
Financial Survey: Mangoceuticals (MGRX) & Its Competitors - Defense World
Mangoceuticals (MGRX) & Its Competitors Financial Analysis - Defense World
Head-To-Head Contrast: Mangoceuticals (MGRX) & The Competition - Defense World
Mangoceuticals (MGRX) versus The Competition Head to Head Survey - Defense World
Reviewing Mangoceuticals (MGRX) & Its Rivals - Defense World
Mangoceuticals (NASDAQ:MGRX) Regains Compliance with Nasdaq Minimum Bid Price Requirement - Defense World
Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) & NewGenIvf Group (NASDAQ:NIVF) - Defense World
Head to Head Review: Mangoceuticals (MGRX) & Its Rivals - Defense World
Financial Analysis: Mangoceuticals (MGRX) vs. Its Peers - Defense World
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire
Mangoceuticals regains full compliance with Nasdaq min bid price requirement - TipRanks
Analyzing Mangoceuticals (MGRX) and Its Competitors - Defense World
Mangoceuticals (MGRX) and Its Peers Financial Comparison - Defense World
Mangoceuticals Inc Stock (MGRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.82%
3.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):